Fucoidan is chemically a high molecular polysaccharide consisting mainly of sugar called "sulfated fucose". Fucoidan is mainly found in the cell wall matrix and is a resistant and barrier component. The structure of fucoidan is complex, and the components and ratios of fucoidan extracted from different brown algae by different extraction methods are different. After research, it was found that the main constituent unit of fucoidan is 1, 2-α-fucose or 1, 3-α-fucose. Research shows that fucoidan has a variety of biological activities. For example, anticoagulant, antitumor, antiviral, hypolipidemic, and immunity-enhancing pharmacological activities.
Fig.1 The metabolic pathway of fucoidan. (Chao, et al., 2018)
CD BioGlyco has been involved in Polysaccharide Analysis for many years, so we offer our clients a full range of fucoidan analysis services. The analytical testing services we provide for fucoidan are:
Fig.2 Analysis procedure of fucoidan. (CD BioGlyco)
Fucoidan is a complex, sulfur-containing polysaccharide found abundantly in the cell walls of brown seaweeds (Phaeophyceae). Renowned for its diverse biological properties, including immunomodulatory, anti-inflammatory, and anti-tumor activities—fucoidan has become a highly sought-after ingredient in the pharmaceutical, nutraceutical, and cosmetic industries.
However, the structural architecture, molecular weight, degree of sulfation, and ultimate bioactivity of fucoidan vary significantly depending on the specific brown algae species from which it is harvested (such as Cladosiphon okamurasaki, Fucus vesiculosus, or Undaria pinnatifida). Because these differences directly dictate market value and clinical efficacy, validating the botanical authenticity and specific algal origin of raw materials is a critical bottleneck for quality control and regulatory compliance.
To address this challenge, CD BioGlyco offers an advanced fucoidan analysis service platform. In this project, our team was commissioned to perform precision metabolomic chemical fingerprinting using high-resolution mass spectrometry to accurately verify the algal sources of three commercial seaweed extract lots.
Traditional crude polysaccharide assays (such as basic total carbohydrate or barium chloride sulfate tests) are unable to differentiate between different species of brown algae once the fucoidan has been extracted and processed into powder form. The client required an ultra-sensitive, reliable, and high-confidence analytical technique to confirm whether their three incoming raw material batches matched their designated biological origins:
Instead of relying solely on standard composition testing, CD BioGlyco's carbohydrate experts deployed a cutting-edge high-resolution mass spectrometry (HRMS) chemical fingerprinting platform paired with proprietary bioinformatics source-prediction models.
Fig.4 MS spectrum of (9Z)-octadec-9-enamide from sample sk-1. (CD BioGlyco)
Fig.5 MS spectrum of hexadecanoic acid from sample sk-1. (CD BioGlyco)
Fig.6 MS spectrum of octadecanoic acid from sample sk-1. (CD BioGlyco)
Fig.7 MS spectrum of 3,7,11-trimethyl-2-(methylamino)-1,3-dodecanediol from sample sk-1. (CD BioGlyco)
Fig.8 MS spectrum of 4-dodecylmorpholine from sample sk-1. (CD BioGlyco)
Fig.9 MS spectrum of tetradecanoic acid from sample sk-1. (CD BioGlyco)
Fig.10 MS spectrum of elaidolinolenic acid from sample sk-1. (CD BioGlyco)
The HRMS metabolic profiling yielded flawless, unambiguous source classification data for all three seaweed extract samples, confirming 100% supply chain transparency for the client:
| Sample ID | sk-1 | sk-2 | sk-3 |
|---|---|---|---|
| Sample Name | Fucoidan Powder (Mozuku) | Fucus vesiculosus extract | Undaria pinnatifida Extract |
| Predicted Algal Source | Mozuku (Cladosiphon okamurasaki) | Fucus vesiculosus (bladderwrack) | Undaria pinnatifida Extract |
| Confidence Level | High | High | High |
| Total Detected Compounds | 36 | 41 | 42 |
| Number of Fucoidan-related Substances | 0 | 0 | 0 |
| Number of Sulfur-containing Compounds | 36 | 41 | 42 |
This project beautifully demonstrates why CD BioGlyco is a premier global partner for marine carbohydrate and fucoidan characterization. By leveraging our fucoidan analysis service, clients gain access to unmatched analytical rigor:
Paper Title: Fucoidans from brown alga Fucus evanescens: structure and biological activity.
Technology: 1H, 13C, and 2D (COSY, TOCSY, ROESY, NOESY, HSQC, and HMBC) nuclear magnetic resonance (NMR) spectroscopy
Journal: Frontiers in Marine Science
Published: 2016
Results: The structures of the obtained modified fucoidans were studied by 1D (1H, 13C) and 2D (COSY, TOCSY, ROESY, NOESY, HSQC, and HMBC) nuclear magnetic resonance (NMR) spectroscopy and methylation analysis. As a result, fucoidan was shown to be a regular molecule containing disaccharide repeating units, with a linear main chain of alternating 2-sulfated 1,3-and 1,4-linked α- L-fucose residues. A methylation analysis of desulfated fucoidan showed that 1,3-and 1,4-linked fucose residues had a ratio of 1.2:1. Few sulfate groups were found in position 4 of some 1,3-linked fucose residues. Acetyl groups occupied the free C-3 of 1,4-linked residues and/or the C-4 of 1,3-linked fucose residues (Fig.3).
Fig.3 Structures of fucoidan from F. evanescens. (Menshova, et al., 2016)
As a recognized expert in the field of polysaccharide analysis, CD BioGlyco has developed a complete workflow for fucoidan analysis and has performed many fucoidan analysis projects. Please feel free to contact us for any of your needs in this area.
References
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.